-
Mashup Score: 1Ethical and Legal Aspects of Treating Bipolar Disorder - 4 month(s) ago
Bipolar disorder is a serious mental illness that is characterized by severe, episodic fluctuations in mood that may be accompanied by psychosis. The illness was the 18th leading cause of disability worldwide in 2010, ahead of Alzheimer’s disease and ischemic heart disease (1). Thirty to 60% of patients with bipolar disorder struggle with social or occupational functioning (2). The National Institute of Mental Health (3) reports that an estimated 4.4% of Americans will be diagnosed as having bipolar
Source: focus.psychiatryonline.orgCategories: General Medicine News, PsychiatryTweet
-
Mashup Score: 0A blood test to diagnose bipolar disorder? - 6 month(s) ago
“The added value of biomarkers was particularly evident in scenarios where data on psychiatric symptoms were unavailable and at intermediate diagnostic thresholds.”
Source: www.mdedge.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 7Blood Test Could Help Diagnose Bipolar Disorder - 6 month(s) ago
Many cases where bipolar disorder was misdiagnosed could be avoided using a simple blood test to identify biomarkers, according to research from the University of Cambridge.
Source: www.medscape.co.ukCategories: General Medicine News, General NewsTweet
-
Mashup Score: 23Blood Test Could Help Diagnose Bipolar Disorder - 6 month(s) ago
Many cases where bipolar disorder was misdiagnosed could be avoided using a simple blood test to identify biomarkers, according to research from the University of Cambridge.
Source: www.medscape.co.ukCategories: General Medicine News, PsychiatryTweet
-
Mashup Score: 7Blood Test Could Help Diagnose Bipolar Disorder - 6 month(s) ago
Many cases where bipolar disorder was misdiagnosed could be avoided using a simple blood test to identify biomarkers, according to research from the University of Cambridge.
Source: www.medscape.co.ukCategories: General Medicine News, General NewsTweet
-
Mashup Score: 0The CANMAT and ISBD Guidelines for the Treatment of Bipolar Disorder: Summary and a 2023 Update of Evidence - 6 month(s) ago
Bipolar disorder is a complex and heterogeneous psychiatric condition that affects more than 2% of the population. The assessment and treatment of bipolar disorder can be a challenge for clinicians, given its clinical complexity and the rapidly changing treatment landscape with the growing range of treatment options that are becoming available for various phases of the illness. To help clinicians navigate the complexity involved in the assessment and management of bipolar disorder, the guidelines of the 2018 Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) synthesized the evidence on the efficacy, safety, and tolerability of treatments for bipolar disorder and translated it into first-, second-, and third‐line treatment recommendations. The main objective of this contribution is to provide clinicians with a summary of the 2018 CANMAT/ISBD guideline recommendations with the addition of any new evidence for the treatment of
Source: focus.psychiatryonline.orgCategories: General Medicine News, PsychiatryTweet
-
Mashup Score: 0The CANMAT and ISBD Guidelines for the Treatment of Bipolar Disorder: Summary and a 2023 Update of Evidence - 6 month(s) ago
Bipolar disorder is a complex and heterogeneous psychiatric condition that affects more than 2% of the population. The assessment and treatment of bipolar disorder can be a challenge for clinicians, given its clinical complexity and the rapidly changing treatment landscape with the growing range of treatment options that are becoming available for various phases of the illness. To help clinicians navigate the complexity involved in the assessment and management of bipolar disorder, the guidelines of the 2018 Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) synthesized the evidence on the efficacy, safety, and tolerability of treatments for bipolar disorder and translated it into first-, second-, and third‐line treatment recommendations. The main objective of this contribution is to provide clinicians with a summary of the 2018 CANMAT/ISBD guideline recommendations with the addition of any new evidence for the treatment of
Source: focus.psychiatryonline.orgCategories: General Medicine News, PsychiatryTweet
-
Mashup Score: 0Smart Bracelet May Predict Mood Changes in Bipolar Disorder - 6 month(s) ago
A wristband that measures skin electrical activity could eventually predict changes in mood in patients with bipolar disorder, and even be used to guide treatment options.
Source: www.medscape.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Large Genomic Analysis Finds Shared Etiology Between Gastrointestinal Tract Diseases and Psychiatric Disorders - 6 month(s) ago
A study involving genomic samples drawn from more than 3 million individuals found a strong statistical correlation between gastrointestinal tract diseases and psychiatric disorders.
Source: psychnews.psychiatryonline.orgCategories: Latest Headlines, PsychiatryTweet
-
Mashup Score: 7
This review discusses current evidence regarding the diagnosis and treatment of bipolar disorder, including differential diagnoses, treatment of mania and depressive episodes, and maintenance treatment.
Source: jamanetwork.comCategories: Hem/Oncs, Latest HeadlinesTweet
Ethical norms regarding patient autonomy and legal standards for involuntary commitment often raise barriers to ensuring the long-term well-being of individuals with #bipolar disorder. https://t.co/aR8z5eHc3B https://t.co/MjIcOfM0iZ